KOVE medical raises CHF 1.6 M

A University of Zurich spin-off, KOVE medical develops an implantable device that closes the foetal membrane after in utero surgery to reduce the risk of preterm birth. The start-up has closed a CHF 1.6 million seed round from a syndicate of business angels to reach first human studies.

Announced on
Round
Seed
Amount
CHF 1.6 M
Location
canton of Zurich
Sector
Health & medtech

Investors

The investors were not named in the announcement.

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic